2 dicembre 2024 – Today, Bank J. Safra Sarasin AG announced the acquisition of 100% of the shares of MIV Asset Management AG, Zurich (MIV).

MIV is renowned for its expertise in medical technology (Medtech) investments and its flagship MIV Global Medtech Fund. The firm is well known for its innovative approach and deep sector knowledge, making it a valuable addition to Bank J. Safra Sarasin's portfolio of thematic equity strategies available to both private and institutional investors.

The Medtech sector is set to grow, driven by an aging global population, technological innovation, the rise of chronical diseases and the increasing healthcare access in emerging markets. Some of the most exciting opportunities, such as AI-driven applications, make it a compelling long-term investment case for investors.

MIV will maintain its existing investment strategy and organisational structure to ensure solid performance and uninterrupted service for clients.

Walder Wyss advised Bank J. Safra Sarasin AG in the transaction on all corporate, regulatory, and tax matters. The team was led by Patrick W. Vogel (Partner, Banking and Corporate/M&A) and further included Laurent Schmidt (Senior Associate, Banking and Corporate/M&A), Stefan Walder (Counsel, Corporate/M&A), and Janine Corti (Counsel, Tax).